NO20042680L - Fremgangsmater for fremstilling av O-demetylvenflaxine - Google Patents

Fremgangsmater for fremstilling av O-demetylvenflaxine

Info

Publication number
NO20042680L
NO20042680L NO20042680A NO20042680A NO20042680L NO 20042680 L NO20042680 L NO 20042680L NO 20042680 A NO20042680 A NO 20042680A NO 20042680 A NO20042680 A NO 20042680A NO 20042680 L NO20042680 L NO 20042680L
Authority
NO
Norway
Prior art keywords
demethylvenflaxine
processes
preparation
Prior art date
Application number
NO20042680A
Other languages
English (en)
Norwegian (no)
Inventor
Beat Theodor Weber
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23309595&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20042680(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20042680L publication Critical patent/NO20042680L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO20042680A 2001-12-04 2004-06-25 Fremgangsmater for fremstilling av O-demetylvenflaxine NO20042680L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33495301P 2001-12-04 2001-12-04
PCT/US2002/038403 WO2003048104A1 (en) 2001-12-04 2002-12-03 Methods for preparing o-desmethylvenlafaxine

Publications (1)

Publication Number Publication Date
NO20042680L true NO20042680L (no) 2004-06-25

Family

ID=23309595

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042680A NO20042680L (no) 2001-12-04 2004-06-25 Fremgangsmater for fremstilling av O-demetylvenflaxine

Country Status (28)

Country Link
US (4) US6689912B2 (de)
EP (1) EP1451143B9 (de)
JP (1) JP4342312B2 (de)
KR (1) KR100939650B1 (de)
CN (1) CN1319934C (de)
AR (1) AR037622A1 (de)
AT (1) ATE403641T1 (de)
AU (1) AU2002357049B2 (de)
BR (1) BR0214701A (de)
CA (1) CA2466779C (de)
CO (1) CO5580816A2 (de)
DE (1) DE60228118D1 (de)
DK (1) DK1451143T3 (de)
EC (1) ECSP045135A (de)
ES (1) ES2311647T4 (de)
HU (1) HUP0402269A3 (de)
IL (3) IL162253A0 (de)
MX (1) MXPA04005309A (de)
NO (1) NO20042680L (de)
NZ (1) NZ533316A (de)
PL (1) PL369299A1 (de)
PT (1) PT1451143E (de)
RU (1) RU2317286C2 (de)
SI (1) SI1451143T1 (de)
TW (1) TWI260982B (de)
UA (1) UA80543C2 (de)
WO (1) WO2003048104A1 (de)
ZA (1) ZA200405250B (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342533B1 (en) * 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
PL350924A1 (en) * 1999-04-06 2003-02-10 Sepracor Inc Derivatives of venlafaxine and methods of preparing and using the same
AU2002250058B2 (en) * 2001-02-12 2007-08-16 Wyeth Llc Novel succinate salt of O-desmethyl-venlafaxine
UA80543C2 (en) * 2001-12-04 2007-10-10 Wyeth Corp Method for the preparation of o-desmethylvenlafaxine
WO2007005961A2 (en) * 2005-07-06 2007-01-11 Sepracor Inc. Combinations of eszopiclone and o-desmethylvenlafaxine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
CA2629609A1 (en) * 2005-12-05 2007-06-14 Wyeth Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexanols
WO2007071404A1 (en) 2005-12-20 2007-06-28 Synthon B.V. Process for making desvenlafaxine
MX2007016179A (es) 2006-04-17 2008-03-11 Teva Pharma Formas cristalinas de o-desmetilvenlafaxina.
WO2007120923A1 (en) 2006-04-17 2007-10-25 Teva Pharmaceutical Industries Ltd. Substantially pure o-desmethylvenlafaxine and processes for preparing it
WO2008035369A2 (en) * 2006-06-30 2008-03-27 Alembic Limited Novel form of o-desmethyl venlafaxine
CA2656167A1 (en) 2006-07-26 2008-01-31 Teva Pharmaceutical Industries Ltd. Processes for the synthesis of o-desmethylvenlafaxine
CA2656166A1 (en) * 2006-07-26 2008-01-31 Teva Pharmaceutical Industries Ltd. Processes for the synthesis of o-desmethylvenlafaxine
US20090062572A1 (en) * 2006-07-26 2009-03-05 Valerie Niddam-Hildesheim Processes for the synthesis of O-desmethylvenlafaxine
WO2008013995A2 (en) * 2006-07-26 2008-01-31 Teva Pharmaceutical Industries Ltd. Tridesmethylvenlafaxine and processes for the synthesis of o-desmethylvenlafaxine
US20080221356A1 (en) * 2006-07-26 2008-09-11 Valerie Niddam-Hildesheim Processes for the synthesis of O-desmethylvenlafaxine
US20090069601A1 (en) * 2006-07-26 2009-03-12 Valerie Niddam-Hildesheim Processes for the synthesis of O-desmethylvenlafaxine
US20090137846A1 (en) * 2006-07-26 2009-05-28 Valerie Niddam-Hildesheim Processes for the synthesis of O-Desmethylvenlafaxine
US20100121108A1 (en) * 2006-08-04 2010-05-13 Medichem, S.A. Process for synthesizing desvenlafaxine free base and salts or solvates thereof
US20100076086A1 (en) * 2007-01-31 2010-03-25 Merck Development Centre Private Limited Plot 1 A/2 Process for the preparation of o-desmethyl venlafaxine
IN2009DN05509A (de) * 2007-03-14 2010-04-30 Teva Pharma
TR200909798T1 (tr) * 2007-07-12 2010-05-21 Dr. Reddy's Laboratories Ltd. O-desmetilvenlafaksin.
WO2009010990A2 (en) * 2007-07-16 2009-01-22 Matrix Laboratories Limited Process for the preparation of o-desmethylvenlafaxine succinate polymorphic forms
WO2009034434A2 (en) * 2007-09-10 2009-03-19 Cadila Pharmaceuticals Limited An improved process for the preparation of o-desmethylvenlafaxine
NZ585368A (en) * 2007-10-26 2012-07-27 Generics Uk Ltd Process for preparing o-desmethylvenlafaxine
CA2706775A1 (en) * 2007-11-26 2009-06-04 Teva Pharmaceutical Industries Ltd. Crystal forms of o-desmethylvenlafaxine fumarate
WO2009084038A2 (en) * 2007-12-28 2009-07-09 Ind-Swift Laboratories Limited Improved process for the preparation of 0-desmethyl-venlafaxine
WO2009151494A1 (en) * 2008-03-06 2009-12-17 Teva Pharmaceutical Industries Ltd. Processes for the preparation of o-desmethylvenlafaxine, free from its dimer impurities
EP2119695A1 (de) 2008-05-16 2009-11-18 Krka Zubereitung von O-Desmethylvenlafaxin-Salzen
EP2119696A1 (de) 2008-05-16 2009-11-18 Krka Zubereitung von O-Desmethylvenlafaxin-Salzen
EP2297087A2 (de) * 2008-06-16 2011-03-23 Teva Pharmaceutical Industries Ltd. Feste formen von o-desmethylvenlafaxinsalzen
US20100016638A1 (en) * 2008-07-21 2010-01-21 Zdenko Hamersak Method for preparation of o-desmethylvenlafaxine using polythiolates
JP2011529481A (ja) * 2008-07-30 2011-12-08 ジェネリクス・（ユーケー）・リミテッド Ｏ−デスメチルベンラファキシンの調製方法
CZ2008756A3 (cs) 2008-11-27 2010-03-24 Zentiva, A. S. Zpusob prípravy desvenlafaxinu a jeho solí
CZ301820B6 (cs) 2009-02-06 2010-06-30 Zentiva, K.S. Nové soli desvenlafaxinu a zpusob jejich prípravy
CZ302145B6 (cs) 2009-07-15 2010-11-10 Zentiva, K. S. Zpusob prípravy desvenlafaxinu a jeho solí
WO2011007136A2 (en) 2009-07-16 2011-01-20 Cipla Limited Process for the preparation of o-desmethyl venlafaxine and intermediate for use therein
US20110098506A1 (en) * 2009-10-26 2011-04-28 Intas Pharmaceuticals Limited Method of preparing o-desmethylvenlafaxine
US20110184067A1 (en) * 2010-01-25 2011-07-28 Intas Pharmaceuticals Ltd. O-desmethylvenlafaxine succinate polymorph & process for preparing thereof
EP2539313A2 (de) * 2010-03-29 2013-01-02 Pliva Hrvatska D.O.O. Kristalline formen von o-desmethylvenlafaxinfumarat
CZ303249B6 (cs) 2010-04-06 2012-06-20 Zentiva, K.S. Zpusob výroby 4-(2-(substituovaných)-1-(1-hydroxycyklohexyl)ethyl)fenolu O-demethylací jejich methyletheru pomocí nepáchnoucích aromatických thiolu
EP2394976A1 (de) 2010-06-11 2011-12-14 LEK Pharmaceuticals d.d. Verfahren zur Demethylierung aromatischer Methylether unter Verwendung von 3-Mercaptopropionsäure
WO2018146529A1 (en) 2017-02-09 2018-08-16 R L Finechem Private Limited A process for preparation of1-[2-(dimethylamino)-1-(4-hydroxyphenyl) ethyl]-cyclohexanol and salts thereof
CN109232189B (zh) * 2018-09-25 2021-10-08 杭州盛弗泰新材料科技有限公司 一种高纯度1-羟基芘的制备方法
CN109665966A (zh) * 2018-11-01 2019-04-23 山东蒲济医药科技有限公司 一种琥珀酸去甲文拉法辛化合物的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2741009A1 (de) * 1976-09-22 1978-03-23 Sandoz Ag 4-styryl-4-indolinol-derivate, ihre verwendung und herstellung
US4535186A (en) 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
CA1227304A (en) 1984-08-01 1987-09-29 Raymond C. Francis Delignification of pulp
GB8902209D0 (en) 1989-02-01 1989-03-22 Wyeth John And Brother Limited Preparation of cyclohexanol derivatives and novel thioamide intermediates
US6197828B1 (en) * 1998-12-01 2001-03-06 Sepracor, Inc. Derivatives of (+)-venlafaxine and methods of preparing and using the same
US6342533B1 (en) * 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
PL350924A1 (en) 1999-04-06 2003-02-10 Sepracor Inc Derivatives of venlafaxine and methods of preparing and using the same
WO2000076955A1 (en) 1999-06-15 2000-12-21 American Home Products Corporation Enantiomers of o-desmethyl venlafaxine
JP2004504026A (ja) 2000-07-18 2004-02-12 バイエル　アクチェンゲゼルシャフト ヒトｄｅｓｃ１様セリンプロテアーゼの調節
AU2002250058B2 (en) * 2001-02-12 2007-08-16 Wyeth Llc Novel succinate salt of O-desmethyl-venlafaxine
UA80543C2 (en) 2001-12-04 2007-10-10 Wyeth Corp Method for the preparation of o-desmethylvenlafaxine

Also Published As

Publication number Publication date
US20040158101A1 (en) 2004-08-12
KR100939650B1 (ko) 2010-02-05
RU2317286C2 (ru) 2008-02-20
UA80543C2 (en) 2007-10-10
CN1625546A (zh) 2005-06-08
NZ533316A (en) 2005-12-23
ES2311647T3 (es) 2009-02-16
BR0214701A (pt) 2004-08-31
AR037622A1 (es) 2004-11-17
IL194034A (en) 2010-12-30
JP2005511681A (ja) 2005-04-28
JP4342312B2 (ja) 2009-10-14
HUP0402269A3 (en) 2010-06-28
TW200301102A (en) 2003-07-01
US20030105358A1 (en) 2003-06-05
ECSP045135A (es) 2004-07-23
US20090018365A1 (en) 2009-01-15
AU2002357049B2 (en) 2009-07-16
US7435854B2 (en) 2008-10-14
RU2004120284A (ru) 2005-04-10
CA2466779A1 (en) 2003-06-12
HK1065778A1 (en) 2005-03-04
US20070225525A1 (en) 2007-09-27
WO2003048104A1 (en) 2003-06-12
ATE403641T1 (de) 2008-08-15
EP1451143B9 (de) 2009-08-12
DK1451143T3 (da) 2008-11-10
AU2002357049A1 (en) 2003-06-17
HUP0402269A2 (hu) 2005-02-28
PT1451143E (pt) 2008-10-21
PL369299A1 (en) 2005-04-18
IL162253A (en) 2009-02-11
CN1319934C (zh) 2007-06-06
US6689912B2 (en) 2004-02-10
ZA200405250B (en) 2005-12-28
CA2466779C (en) 2013-11-19
SI1451143T1 (sl) 2008-12-31
CO5580816A2 (es) 2005-11-30
EP1451143A1 (de) 2004-09-01
TWI260982B (en) 2006-09-01
EP1451143B1 (de) 2008-08-06
DE60228118D1 (de) 2008-09-18
ES2311647T4 (es) 2009-11-10
IL162253A0 (en) 2005-11-20
KR20050044671A (ko) 2005-05-12
MXPA04005309A (es) 2004-09-13

Similar Documents

Publication Publication Date Title
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
NO20040027L (no) Fremgangsmate for fremstillingen av escitalopram
DK1448205T3 (da) Kombinationer til behandling af immunoinflammatoriske sygdomme
NO20030163L (no) Fremgangsmate for fremstilling av olefiner
NO20040278L (no) Fremgangsmate for fremstilling av perindopril
NO20042667L (no) Fremgangsmate for fremstilling av escitalopram
FI20011541A0 (fi) Menetelmä massan valmistamiseksi
NO20040482L (no) Fremgangsmåte til fremstilling av tolterodin.
NO20041200L (no) Fremgangsmate for fremstilling av citalopram.
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
NO20034123L (no) Fremgangsmåte for behandling av brennstoff
NO20041968L (no) Anvendelse av cystationin
NO20034003D0 (no) Fremgangsmåte for fremstilling av imidazol-forbindelser
NO20023445L (no) Fremgangsmåte for fremstilling av peptider
NO20035538D0 (no) Fremgangsmåte for fremstilling av zaleplon
NO20042640L (no) Fremgangsmate for fremstilling av ekinocandinderivater
NO20030515L (no) Fremgangsmåte for fremstilling av dinapsolin
NO20035586L (no) Fremgangsmate for fremstilling av cykloheksanol-derivater
NO20035136D0 (no) Fremgangsmåte til fremstilling av imipenem
NO20042202L (no) Fremgangsmate for fremstilling av asymmetriske karotenoider
FI20010472A0 (fi) Menetelmä alfa-pineenin hydraamiseksi
NO20023702L (no) Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
FI20010892A0 (fi) Menetelmä ksylitolin valmistamiseksi
NO20035138D0 (no) Fremgangsmåte til fremstilling av amorft natriumsilastatin

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application